Centessa Pharmaceuticals PLC (CNTA)
8.865
-0.08
(-0.95%)
USD |
NASDAQ |
May 17, 16:00
8.865
0.00 (0.00%)
After-Hours: 20:00
Centessa Pharmaceuticals Total Assets (Quarterly): 328.17M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 328.17M |
| December 31, 2023 | 360.25M |
| September 30, 2023 | 377.36M |
| June 30, 2023 | 392.92M |
| March 31, 2023 | 403.86M |
| December 31, 2022 | 444.31M |
| September 30, 2022 | 479.36M |
| Date | Value |
|---|---|
| June 30, 2022 | 521.05M |
| March 31, 2022 | 582.19M |
| December 31, 2021 | 629.64M |
| September 30, 2021 | 612.21M |
| June 30, 2021 | 643.76M |
| March 31, 2021 | 320.52M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
320.52M
Minimum
Mar 2021
643.76M
Maximum
Jun 2021
468.89M
Average
444.31M
Median
Dec 2022
Total Assets (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | 258.01M |
| Biodexa Pharmaceuticals Plc | 13.43M |
| Verona Pharma PLC | 289.91M |
| NuCana PLC | 35.43M |
| Autolus Therapeutics PLC | 375.38M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 113.01M |
| Shareholders Equity (Quarterly) | 215.16M |